Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.
暂无分享,去创建一个
Kensuke Shibata | Taroh Kinoshita | Takeshi Yamada | Naoya Ohara | S. Yoshida | N. Maeda | Y. Yoshikai | T. Kinoshita | N. Ohara | W. Wajjwalku | Takeshi Yamada | Yasunobu Yoshikai | Ce Tang | Hisakata Yamada | Naoyoshi Maeda | Shinichi Yoshida | Worawidh Wajjwalku | K. Shibata | Ce Tang | H. Yamada
[1] J. Sprent,et al. Antiviral CD4+ memory T cells are IL-15 dependent , 2007, The Journal of experimental medicine.
[2] P. Morrissey,et al. Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice , 2000, The Journal of experimental medicine.
[3] M. Patarroyo,et al. Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG , 1986, Infection and immunity.
[4] J. Flynn,et al. Induction of Mycobacterium tuberculosis-Specific Primary and Secondary T-Cell Responses in Interleukin-15-Deficient Mice , 2005, Infection and Immunity.
[5] T. Matsuguchi,et al. Overexpression of IL-15 In Vivo Enhances Protection Against Mycobacterium bovis Bacillus Calmette-Guérin Infection Via Augmentation of NK and T Cytotoxic 1 Responses1 , 2001, The Journal of Immunology.
[6] I. Orme,et al. Materials and Methods Briefdefinitive Report Disseminated Tuberculosis in Interferon 7 Gene-disrupted Mice , 2022 .
[7] S. Mittal,et al. Does B.C.G. vaccination prevent or postpone the occurrence of tuberculous meningitis? , 1996, Indian journal of pediatrics.
[8] H. McShane,et al. Protective Immunity against Mycobacterium tuberculosis Induced by Dendritic Cells Pulsed with both CD8+- and CD4+-T-Cell Epitopes from Antigen 85A , 2002, Infection and Immunity.
[9] N. Dhar,et al. Skewing of the Th1/Th2 responses in mice due to variation in the level of expression of an antigen in a recombinant BCG system. , 2003, Immunology letters.
[10] J. Flynn,et al. Induction of M3-Restricted Cytotoxic T Lymphocyte Responses by N-Formylated Peptides Derived from Mycobacterium tuberculosis , 2001, The Journal of experimental medicine.
[11] N. Ohara,et al. Protective responses against experimental Mycobacterium leprae infection in mice induced by recombinant Bacillus Calmette-Guérin over-producing three putative protective antigen candidates. , 2001, Vaccine.
[12] S. Kaufmann. Tuberculosis: back on the immunologists' agenda. , 2006, Immunity.
[13] I. Orme,et al. Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.
[14] C S Berkey,et al. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. , 1995, Pediatrics.
[15] T. Dassopoulos,et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. , 1998, Immunity.
[16] C S Berkey,et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. , 1994, JAMA.
[17] J. Bennedsen,et al. Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG , 1988, Infection and immunity.
[18] S. Matsumoto,et al. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2. , 2000, The Journal of urology.
[19] Malin,et al. Human cytolytic and interferon g-secreting CD 8 1 T lymphocytes specific for Mycobacterium tuberculosis , 1997 .
[20] L. Lefrançois,et al. Cutting Edge: Requirement for IL-15 in the Generation of Primary and Memory Antigen-Specific CD8 T Cells1 , 2002, The Journal of Immunology.
[21] Yi Luo,et al. Manipulation of immune responses to Mycobacterium bovis by vaccination with IL‐2‐ and IL‐18‐secreting recombinant bacillus Calmette Guerin , 2002, Immunology and cell biology.
[22] C. Dye,et al. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.
[23] S. Ehlers,et al. Interleukin‐15 mediates protection against experimental tuberculosis: A role for NKG2D‐dependent effector mechanisms of CD8+ T cells , 2006, European journal of immunology.
[24] 土居 岳彦. H2-M3-restricted CD8[+] T cells induced by peptide-pulsed dendritic cells confer protection against Mycobacterium tuberculosis , 2007 .
[25] N. Ohara,et al. Characterization of the transcriptional initiation regions of genes for the major secreted protein antigens 85C and MPB51 of Mycobacterium bovis BCG. , 1997, Microbial pathogenesis.
[26] F. Sallusto,et al. Cytokine-driven Proliferation and Differentiation of Human Naive, Central Memory, and Effector Memory CD4+ T Cells , 2001, The Journal of experimental medicine.
[27] T. Yamada,et al. Cloning and expression of the Mycobacterium bovis BCG gene for extracellular alpha antigen , 1988, Journal of bacteriology.
[28] S. Cole,et al. Differential Effects of Prior Exposure to Environmental Mycobacteria on Vaccination with Mycobacterium bovis BCG or a Recombinant BCG Strain Expressing RD1 Antigens , 2005, Infection and Immunity.
[29] J. Flynn,et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.
[30] L. Culp,et al. Induction of monocyte expression of tumor necrosis factor alpha by the 30-kD alpha antigen of Mycobacterium tuberculosis and synergism with fibronectin. , 1996, The Journal of clinical investigation.
[31] J. Bramson,et al. Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[32] P. Dierckx,et al. Specific Lymphoproliferation, Gamma Interferon Production, and Serum Immunoglobulin G Directed against a Purified 32 kDa Mycobacterial Protein Antigen (P32) in Patients with Active Tuberculosis , 1988, Scandinavian journal of immunology.
[33] P. Ohashi,et al. Differential Roles of Interleukin 15 mRNA Isoforms Generated by Alternative Splicing in Immune Responses in Vivo , 2000, The Journal of experimental medicine.
[34] T. Hara,et al. H2-M3-Restricted CD8+ T Cells Induced by Peptide-Pulsed Dendritic Cells Confer Protection against Mycobacterium tuberculosis1 , 2007, The Journal of Immunology.
[35] K. Takatsu,et al. The immunogenic peptide for Th1 development. , 2003, International immunopharmacology.
[36] T. Yamada,et al. Cloning and expression of the gene for the cross-reactive alpha antigen of Mycobacterium kansasii , 1990, Infection and immunity.
[37] P. Burkett,et al. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. , 2006, Annual review of immunology.
[38] Leo Lefrançois,et al. Cytokine control of memory T-cell development and survival , 2003, Nature Reviews Immunology.
[39] H. Dockrell,et al. Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[40] D. Busch,et al. Memory phenotype CD8+ T cells in IL‐15 transgenic mice are involved in early protection against a primary infection with Listeria monocytogenes , 2001, European journal of immunology.
[41] J. Sprent,et al. IL-7 regulates basal homeostatic proliferation of antiviral CD4+T cell memory. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[42] P. Andersen,et al. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells , 2000, European journal of immunology.
[43] L. Bradley,et al. Interleukin 7 Regulates the Survival and Generation of Memory CD4 Cells , 2003, The Journal of experimental medicine.
[44] N. Dhar,et al. Immunogenicity of recombinant BCG vaccine strains overexpressing components of the antigen 85 complex of Mycobacterium tuberculosis , 2004, Medical Microbiology and Immunology.
[45] J. Flynn,et al. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. , 1999, Journal of immunology.
[46] H. Kuwano,et al. IL-15 Regulates CD8+ T Cell Contraction during Primary Infection1 , 2006, The Journal of Immunology.
[47] M. O'Donnell,et al. IL-2-secreting recombinant bacillus Calmette Guerin can overcome a Type 2 immune response and corticosteroid-induced immunosuppression to elicit a Type 1 immune response. , 2002, International immunology.
[48] M. H. Merrill,et al. USE AND CARE OF LABORATORY ANIMALS. , 1964, Public health reports.
[49] G. Kaplan,et al. Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity. , 2000, Microbial pathogenesis.
[50] F. Sallusto,et al. Cytokine-driven proliferation and differentiation of human naïve, central memory and effector memory CD4+ T cells. , 2003, Pathologie-biologie.
[51] N. Guérin,et al. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui. , 1995, International journal of epidemiology.
[52] P. Marrack,et al. Not all CD4+ memory T cells are long lived , 2006, Immunological reviews.